Oncology & Cancer
Breakthrough drug on fast-track to help leukemia patients
Three very different people gathered recently at University of Colorado Hospital. They were linked by leukemia.
Feb 28, 2014
1
29
Page 17 - News tagged with leukemia drug
Oncology & Cancer
Idelalisib shows promise in treating indolent non-Hodgkin lymphomas
Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time.
Jan 22, 2014
0
0
Oncology & Cancer
Antipsychotic drug exhibits cancer-fighting properties
In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic ...
Jan 9, 2014
0
0
Oncology & Cancer
New drug combo might help older, sicker patients with leukemia
(HealthDay)—A new combination of drugs might prolong life in certain older leukemia patients, a new study suggests.
Jan 9, 2014
0
0
Oncology & Cancer
FDA approves leukemia drug from Roche
The Food and Drug Administration has approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.
Nov 1, 2013
0
0
Diseases, Conditions, Syndromes
Potential new treatment for colitis
A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta.
Oct 23, 2013
1
0
Oncology & Cancer
Anchoring ABL for a better fate
Chronic Myelogenous Leukemia (CML) is a cancer of the white blood cells that is most commonly found in adults and in the elderly. Its incidence has been estimated to be 1 to 2 in 100,000 people. CML was the first cancer to ...
Aug 27, 2013
0
0
Oncology & Cancer
Study suggests way to fight therapy resistant leukemia by blocking DNA repair
New research posted online by the Nature journal Leukemia suggests blocking part of a DNA repair complex that helps some types of leukemia resist treatment can increase the effectiveness of chemotherapy and enhance survival.
Aug 8, 2013
0
0
Oncology & Cancer
Technologies for monitoring remaining leukemia after treatment may help predict patient outcomes
New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes ...
Jul 9, 2013
0
0
Oncology & Cancer
'Undruggable' may be druggable: A new target for cancer drug development
Harvard Stem Cell Institute (HSCI) researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.
Jun 17, 2013
0
0
